• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国肾脏病学会2022年低钠血症诊断和管理争议问题指南

Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia.

作者信息

Lee Yeonhee, Yoo Kyung Don, Baek Seon Ha, Kim Yang Gyun, Kim Hyo Jin, Ryu Ji Young, Paek Jin Hyuk, Suh Sang Heon, Oh Se Won, Lee Jeonghwan, Jhee Jong Hyun, Suh Jin-Soon, Yang Eun Mi, Park Young Ho, Kim Yae Lim, Choi Miyoung, Oh Kook-Hwan, Kim Sejoong

机构信息

Division of Nephrology, Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu, Republic of Korea.

Division of Nephrology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

出版信息

Kidney Res Clin Pract. 2022 Jul;41(4):393-411. doi: 10.23876/j.krcp.33.555. Epub 2022 Jul 28.

DOI:10.23876/j.krcp.33.555
PMID:35919925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346392/
Abstract

The Korean Society for Electrolyte and Blood Pressure Research, in collaboration with the Korean Society of Nephrology, has published a clinical practice guideline (CPG) document for hyponatremia treatment. The document is based on an extensive evidence-based review of the diagnosis, evaluation, and treatment of hyponatremia with the multidisciplinary participation of representative experts in hyponatremia with methodologist support for guideline development. This CPG consists of 12 recommendations (two for diagnosis, eight for treatment, and two for special situations) based on eight detailed topics and nine key questions. Each recommendation begins with statements graded by the strength of the recommendations and the quality of the evidence. Each statement is followed by rationale supporting the recommendations. The committee issued conditional recommendations in favor of rapid intermittent bolus administration of hypertonic saline in severe hyponatremia, the use of vasopressin receptor antagonists in heart failure with hypervolemic hyponatremia, and syndrome of inappropriate antidiuresis with moderate to severe hyponatremia, the individualization of desmopressin use, and strong recommendation on the administration of isotonic fluids as maintenance fluid therapy in hospitalized pediatric patients. We hope that this CPG will provide useful recommendations in practice, with the aim of providing clinical support for shared decision-making to improve patient outcomes.

摘要

韩国电解质与血压研究学会与韩国肾脏病学会合作,发布了一份低钠血症治疗的临床实践指南(CPG)文件。该文件基于对低钠血症诊断、评估和治疗的广泛循证综述,由低钠血症领域的代表性专家多学科参与,并在方法学家的支持下制定指南。本CPG基于八个详细主题和九个关键问题,包含12条推荐意见(两条关于诊断,八条关于治疗,两条关于特殊情况)。每条推荐意见开头均有依据推荐强度和证据质量分级的陈述。每条陈述后均有支持该推荐意见的理由。委员会发布了有条件推荐意见,支持在严重低钠血症时快速间歇性推注高渗盐水,在伴有高血容量性低钠血症的心力衰竭以及伴有中度至重度低钠血症的抗利尿激素分泌失调综合征中使用血管加压素受体拮抗剂,去氨加压素使用个体化,以及强烈推荐在住院儿科患者中使用等渗液作为维持液治疗。我们希望本CPG能在实践中提供有用的推荐意见,旨在为共同决策提供临床支持以改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2167/9346392/5ef00a349243/j-krcp-33-555f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2167/9346392/42daa596704d/j-krcp-33-555f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2167/9346392/5ef00a349243/j-krcp-33-555f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2167/9346392/42daa596704d/j-krcp-33-555f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2167/9346392/5ef00a349243/j-krcp-33-555f2.jpg

相似文献

1
Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia.韩国肾脏病学会2022年低钠血症诊断和管理争议问题指南
Kidney Res Clin Pract. 2022 Jul;41(4):393-411. doi: 10.23876/j.krcp.33.555. Epub 2022 Jul 28.
2
Korean Society of Nephrology 2022 Recommendations on Controversial Issues in Diagnosis and Management of Hyponatremia.韩国肾脏病学会2022年低钠血症诊断和管理争议问题推荐意见
Electrolyte Blood Press. 2022 Jun;20(1):21-38. doi: 10.5049/EBP.2022.20.1.21. Epub 2022 Jun 30.
3
Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia.韩国肾脏病学会 2022 年关于低钠血症诊断和管理中争议问题的建议。
Korean J Intern Med. 2022 Nov;37(6):1120-1137. doi: 10.3904/kjim.2022.174. Epub 2022 Oct 17.
4
Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment.韩国肾脏病学会 2021 年最佳血液透析治疗临床实践指南执行摘要。
Korean J Intern Med. 2022 Jul;37(4):701-718. doi: 10.3904/kjim.2021.543. Epub 2022 Jun 3.
5
Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.韩国肾脏病学会2021年最佳血液透析治疗临床实践指南执行摘要
Kidney Res Clin Pract. 2021 Dec;40(4):578-595. doi: 10.23876/j.krcp.21.700. Epub 2021 Dec 10.
6
Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements.低钠血症的诊断与治疗:临床实践指南与共识声明的系统评价
BMC Med. 2014 Dec 11;12:1. doi: 10.1186/s12916-014-0231-1.
7
SIAD: practical recommendations for diagnosis and management.抗利尿激素分泌异常综合征:诊断与管理的实用建议
J Endocrinol Invest. 2016 Sep;39(9):991-1001. doi: 10.1007/s40618-016-0463-3. Epub 2016 Apr 19.
8
Diagnosis and Management of Hyponatremia: A Review.低钠血症的诊断与治疗:综述
JAMA. 2022 Jul 19;328(3):280-291. doi: 10.1001/jama.2022.11176.
9
The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.国际复苏联合委员会(ILCOR)关于儿科和新生儿患者的科学共识及治疗建议:儿科基础与高级生命支持
Pediatrics. 2006 May;117(5):e955-77. doi: 10.1542/peds.2006-0206. Epub 2006 Apr 17.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
Correspondence on Letter regarding "Evidence-based hyponatremia management in liver disease".关于“肝病中基于证据的低钠血症管理”信件的通信
Clin Mol Hepatol. 2023 Oct;29(4):1048-1049. doi: 10.3350/cmh.2023.0261. Epub 2023 Aug 14.
2
Evidence-based hyponatremia management in liver disease.基于证据的肝脏疾病低钠血症管理。
Clin Mol Hepatol. 2023 Oct;29(4):924-944. doi: 10.3350/cmh.2023.0090. Epub 2023 Jun 5.
3
Evaluation and management of hypernatremia in adults: clinical perspectives.成人高钠血症的评估和管理:临床视角。

本文引用的文献

1
Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study.有症状低钠血症患者中copeptin水平与高渗盐水输注治疗反应之间的关联:一项前瞻性队列研究。
Kidney Res Clin Pract. 2021 Sep;40(3):371-382. doi: 10.23876/j.krcp.20.233. Epub 2021 Jul 8.
2
Comparison of isotonic versus hypotonic intravenous fluid for maintenance fluid therapy in neonates more than or equal to 34 weeks of gestational age - a randomized clinical trial.等张与低张静脉输液在胎龄大于或等于 34 周的新生儿中维持液体治疗的比较 - 一项随机临床试验。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):6338-6345. doi: 10.1080/14767058.2021.1911998. Epub 2021 Apr 20.
3
Korean J Intern Med. 2023 May;38(3):290-302. doi: 10.3904/kjim.2022.346. Epub 2022 Dec 29.
Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment.在接受呋塞米治疗的慢性肾脏病心力衰竭患者中,与增加呋塞米剂量相比加用托伐普坦的疗效比较
Circ Rep. 2018 Dec 12;1(1):35-41. doi: 10.1253/circrep.CR-18-0002.
4
Hyponatraemia despite isotonic maintenance fluid therapy: a time series intervention study.尽管使用等渗维持液治疗,仍出现低钠血症:一项时间序列干预研究。
Arch Dis Child. 2021 Apr 21;106(5):491-495. doi: 10.1136/archdischild-2019-318555.
5
Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.高渗盐水治疗症状性低钠血症患者的快速间歇性推注与缓慢连续输注治疗的矫枉过正风险:SALSA 随机临床试验。
JAMA Intern Med. 2021 Jan 1;181(1):81-92. doi: 10.1001/jamainternmed.2020.5519.
6
Risk of Electrolyte Disorders in Acutely Ill Children Receiving Commercially Available Plasmalike Isotonic Fluids: A Randomized Clinical Trial.商业供应的类血浆等张液在急性病儿童中引起电解质紊乱的风险:一项随机临床试验。
JAMA Pediatr. 2021 Jan 1;175(1):28-35. doi: 10.1001/jamapediatrics.2020.3383.
7
The Role of Fractional Excretion of Uric Acid in the Differential Diagnosis of Hypotonic Hyponatraemia in Patients with Diuretic Therapy.尿酸排泄分数在接受利尿剂治疗的患者低渗性低钠血症鉴别诊断中的作用
Cureus. 2020 Apr 21;12(4):e7762. doi: 10.7759/cureus.7762.
8
Renoprotective effect of tolvaptan in patients with new-onset acute heart failure.托伐普坦对新发急性心力衰竭患者的肾脏保护作用。
ESC Heart Fail. 2020 Aug;7(4):1764-1770. doi: 10.1002/ehf2.12738. Epub 2020 May 7.
9
Comparison of isotonic and hypotonic intravenous fluids in term newborns: is it time to quit hypotonic fluids.等张与低张静脉输液在足月新生儿中的比较:是否到了停用低张液的时候。
J Matern Fetal Neonatal Med. 2022 Jan;35(2):356-361. doi: 10.1080/14767058.2020.1718094. Epub 2020 Mar 29.
10
Hyponatremia in Acute Stroke: To Treat or Not to Treat?急性卒中中的低钠血症:治疗还是不治疗?
J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104421. doi: 10.1016/j.jstrokecerebrovasdis.2019.104421. Epub 2019 Oct 1.